Fig. 2From: Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studiesAdjusted geometric mean symptom-limited endurance time after 6 weeks in Studies 1222.37 and 1222.38 (full analysis set). SE standard errorBack to article page